No Man

Sign in

Join Free
Post RFQ

Pexidartinib (PLX3397)

TypeName: Business Offer

Category:

Offer Date:2018/09/29

Country: United States

Summary: Pexidartinib (PLX3397) is an oral, potent mutil-targeted receptor tyrosine kinase inhibitor of CSF-1R with IC50 of 20 nM, Kit with IC50 of 10 nM, and Flt3 with IC50 160 nM. Phase 3, respectively.
https://www.bocsci.com/pexidartinib-plx3397-cas-1029044-16-3-item-470807.html

Description: [RequestDescription]

OfferId: 2135

Name:Alex Brown

Telphone:

Email:[email protected]